Gender Discrimination Suits: Cases Against Pharma Continue Even As Payouts Slow
This article was originally published in The Pink Sheet Daily
Novartis will pay $8m to settle second case; last year Daiichi Sankyo settled gender discrimination class action for the same amount and action against Bayer was dismissed following confidential resolution. Cases are ongoing against Merck and Forest.
You may also be interested in...
Merck is the sixth pharmaceutical company to be hit with a sales rep gender discrimination class action by Sanford Heisler; similar complaints have survived motions to dismiss filed in wake of Supreme Court’s Wal-Mart v. Dukes ruling.
Forest is the fourth pharmaceutical company to face a sales rep gender discrimination class action by Sanford Wittels & Heisler; complaint seeks $100 million in damage as well as changes in pay and promotion.
The attorneys who won a gender discrimination suit against Novartis Pharmaceuticals Corp. said they would have had a tough time prevailing if they'd gone to court after the Supreme Court's ruling in the Wal-Mart gender discrimination class action.